Exenatide treatment causes suppression of serum fasting ghrelin levels in patients with type 2 diabetes mellitus

Guclu M., Kiyici S., Gul Z., ÇAVUN S.

ENDOCRINE CONNECTIONS, cilt.7, sa.1, ss.193-198, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 7 Sayı: 1
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1530/ec-17-0242
  • Dergi Adı: ENDOCRINE CONNECTIONS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.193-198
  • Anahtar Kelimeler: exenatide, ghrelin, diabetes, GLYCEMIC CONTROL, INSULIN, WEIGHT, EXENDIN-4, METFORMIN, PEPTIDE, GLP-1, CELL
  • Bursa Uludağ Üniversitesi Adresli: Evet

Özet

Aim: In the present study, we investigated the long-term effects of exenatide treatment on serum fasting ghrelin levels in patients with type 2 diabetes mellitus.